Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Sales | 0 | 0 | 0 | 0 | 5,000 |
| Gross Profit | N/A | N/A | N/A | N/A | 5,000 |
| Operating Expenses | 5,699 | 9,176 | 8,701 | 10,355 | 8,218 |
| Operating Income | -5,699 | -9,176 | -8,701 | -10,355 | -3,218 |
| Other Income | 1,556 | 62 | 80 | 108 | 122 |
| Pre-tax Income | -4,143 | -9,114 | -8,621 | -10,247 | -3,096 |
| Net Income Continuous | -4,143 | -9,114 | -8,621 | -10,247 | -3,096 |
| Net Income Extraordinary | 2,639 | N/A | N/A | N/A | N/A |
| Net Income | $-1,504 | $-9,114 | $-8,375 | $-10,247 | $-3,096 |
| EPS Basic Total Ops | -0.02 | -0.13 | -0.12 | -0.15 | -0.05 |
| EPS Basic Continuous Ops | -0.06 | -0.13 | -0.12 | -0.15 | -0.05 |
| EPS Diluted Total Ops | -0.02 | -0.13 | -0.12 | -0.15 | -0.05 |
| EPS Diluted Continuous Ops | -0.06 | -0.13 | -0.12 | -0.15 | -0.05 |
| EBITDA(a) | $-5,690 | $-9,166 | $-8,687 | $-10,343 | $-3,208 |